{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:38:21Z","timestamp":1790519901786,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Immunosuppression therapy is ineffective at preventing chronic rejection of lung allografts (bronchiolitis obliterans syndrome [BOS]) and proinflammatory cytokines by steroid-resistant lymphocytes. The class III NAD-sirtuin 1 (SIRT1) is an important negative regulator of inflammation; however, SIRT1 activity following lung transplant has not been studied. We hypothesized that SIRT1 expression is decreased in proinflammatory lymphocytes following lung transplant and that treatment with SIRT1 activators (resveratrol, curcumin) and agents that prevent NAD depletion (theophylline) upregulate SIRT1 and reduce proinflammatory cytokine expression in these cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Intracellular proinflammatory cytokines and SIRT1 were measured in blood T, natural killer T-like cell (NKT-like), and natural killer (NK) cells from patients with BOS (n = 10), stable lung transplant patients (n = 11), and healthy aged-matched controls (n = 10). Blood was cultured in the presence of \u00b125 \u00b5M resveratrol, \u00b11 \u00b5M curcumin, \u00b15\u2009mg\/L theophylline, \u00b11\u00b5M prednisolone and cytokines, and SIRT1 assessed using flow cytometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>There was a loss of SIRT1 in T, NK-like, and NK cells in BOS patients compared with stable patients and controls (%CD8<jats:sup>+<\/jats:sup> SIRT1<jats:sup>+<\/jats:sup> T cells: 17 \u00b1 10; 37 \u00b1 10; 30 \u00b1 10) (mean \u00b1 SEM BOS, stable, control, respectively) (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 for all). Loss of SIRT1 was associated with increased T, NKT-like, and NK cells expressing interferon (IFN)\u03b3 and tumor necrosis factor (TNF)\u03b1. SIRT1 expression by T cells significantly associated with FEV1 (R = 0.655, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006) and with time posttransplant (R = \u22120.552, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.041). All treatments upregulated SIRT1 and inhibited IFN\u03b3 and TNF\u03b1 production by T, NK, and NKT-like cells additively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>BOS is associated with decreased SIRT1 in peripheral blood proinflammatory T, NK, and NKT-like lymphocytes following lung transplant. Treatment options that increase SIRT1 may improve graft survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002817","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T03:44:05Z","timestamp":1560570245000},"page":"2255-2263","source":"Crossref","is-referenced-by-count":7,"title":["BOS Is Associated With Decreased SIRT1 in Peripheral Blood Proinflammatory T, NK, and NKT-like Lymphocytes"],"prefix":"10.1097","volume":"103","author":[{"given":"Greg","family":"Hodge","sequence":"first","affiliation":[{"name":"Department of Thoracic Medicine, Lung Research, Hanson Institute, Royal Adelaide Hospital, Adelaide, South Australia."},{"name":"Department of Medicine, University of Adelaide, Adelaide, South Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hodge","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Lung Research, Hanson Institute, Royal Adelaide Hospital, Adelaide, South Australia."},{"name":"Department of Medicine, University of Adelaide, Adelaide, South Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Lung Research, Hanson Institute, Royal Adelaide Hospital, Adelaide, South Australia."},{"name":"Department of Medicine, University of Adelaide, Adelaide, South Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Lung Research, Hanson Institute, Royal Adelaide Hospital, Adelaide, South Australia."},{"name":"Department of Medicine, University of Adelaide, Adelaide, South Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Li","family":"Holmes-Liew","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Lung Research, Hanson Institute, Royal Adelaide Hospital, Adelaide, South Australia."},{"name":"Department of Medicine, University of Adelaide, Adelaide, South Australia."},{"name":"Department of Thoracic Medicine, Royal Adelaide Hospital, South Australian Lung Transplant Service, Adelaide, South Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Holmes","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Lung Research, Hanson Institute, Royal Adelaide Hospital, Adelaide, South Australia."},{"name":"Department of Medicine, University of Adelaide, Adelaide, South Australia."},{"name":"Department of Thoracic Medicine, Royal Adelaide Hospital, South Australian Lung Transplant Service, Adelaide, South Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.transproceed.2005.02.032","article-title":"Analysis of lung transplant recipients surviving beyond 5 years.","volume":"37","author":"Lama","year":"2005","journal-title":"Transplant Proc"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2249.2005.02711.x","article-title":"A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation.","volume":"139","author":"Corris","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2249.2005.02671.x","article-title":"Intracellular cytokines in blood T cells in lung transplant patients\u2013a more relevant indicator of immunosuppression than drug levels.","volume":"139","author":"Hodge","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1440-1843.2011.02075.x","article-title":"Increased natural killer T-like cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant recipients.","volume":"17","author":"Hodge","year":"2012","journal-title":"Respirology"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2249.2010.04186.x","article-title":"Time post-lung transplant correlates with increasing peripheral blood T cell granzyme B and proinflammatory cytokines.","volume":"161","author":"Hodge","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/TP.0b013e3181d75971","article-title":"Lymphocytic bronchiolitis is associated with inadequate suppression of blood T-cell granzyme B, IFN-gamma, and TNF-alpha.","volume":"89","author":"Hodge","year":"2010","journal-title":"Transplantation"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/TP.0b013e3181ac170f","article-title":"Bronchiolitis obliterans syndrome is associated with absence of suppression of peripheral blood th1 proinflammatory cytokines.","volume":"88","author":"Hodge","year":"2009","journal-title":"Transplantation"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2249.2009.04008.x","article-title":"Increased levels of T cell granzyme b in bronchiolitis obliterans syndrome are not suppressed adequately by current immunosuppressive regimens.","volume":"158","author":"Hodge","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2012.04.007","article-title":"Bronchiolitis obliterans syndrome is associated with increased peripheral blood natural killer and natural killer T-like granzymes, perforin, and T-helper-type 1 pro-inflammatory cytokines.","volume":"31","author":"Hodge","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1183\/09031936.05.00117504","article-title":"Histone acetylation and deacetylation: importance in inflammatory lung diseases.","volume":"25","author":"Barnes","year":"2005","journal-title":"Eur Respir J"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/lt.24821","article-title":"Sirtuin 1 attenuates inflammation and hepatocellular damage in liver transplant ischemia\/reperfusion: from mouse to human.","volume":"23","author":"Nakamura","year":"2017","journal-title":"Liver Transpl"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.bbrc.2005.10.159","article-title":"Theophylline prevents NAD+ depletion via PARP-1 inhibition in human pulmonary epithelial cells.","volume":"338","author":"Moonen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1074\/jbc.M110.176842","article-title":"Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism.","volume":"286","author":"Vetterli","year":"2011","journal-title":"J Biol Chem"},{"key":"R15-20231002","first-page":"141","article-title":"Anti-inflammatory properties of curcumin, a major constituent of curcuma longa: a review of preclinical and clinical research.","volume":"14","author":"Jurenka","year":"2009","journal-title":"Altern Med Rev"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1074\/jbc.M109.088682","article-title":"SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.","volume":"285","author":"Pacholec","year":"2010","journal-title":"J Biol Chem"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1753425917733531","article-title":"The SIRT1 inhibitor EX-527 suppresses mTOR activation and alleviates acute lung injury in mice with endotoxiemia.","volume":"23","author":"Huang","year":"2017","journal-title":"Innate Immun"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"e75139","DOI":"10.1371\/journal.pone.0075139","article-title":"Resveratrol inhibits CD4+ T cell activation by enhancing the expression and activity of sirt1.","volume":"8","author":"Zou","year":"2013","journal-title":"PLOS One"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/carcin\/bgp229","article-title":"Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice.","volume":"30","author":"Moghaddam","year":"2009","journal-title":"Carcinogenesis"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jtcvs.2008.10.044","article-title":"CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury.","volume":"137","author":"Yang","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1097\/TP.0000000000001592","article-title":"BOS is associated with increased cytotoxic proinflammatory CD8 T, NKT-like, and NK cells in the small airways.","volume":"101","author":"Hodge","year":"2017","journal-title":"Transplantation"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cei.13221","article-title":"BOS is associated with decreased HDAC2 from steroid resistant lymphocytes in the small airways.","volume":"195","author":"Hodge","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2213-2600(18)30240-6","article-title":"The death of low-dose oral theophylline for COPD?","volume":"6","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1183\/09059180.00001313","article-title":"Small airways diseases, excluding asthma and COPD: an overview.","volume":"22","author":"Burgel","year":"2013","journal-title":"Eur Respir Rev"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20161066","article-title":"Metabolic reprogramming of human CD8+ memory T cells through loss of SIRT1.","volume":"215","author":"Jeng","year":"2018","journal-title":"J Exp Med"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cei.12081","article-title":"Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28NULL T cells in bronchiolitis obliterans syndrome.","volume":"173","author":"Hodge","year":"2013","journal-title":"Clin Exp Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:29:33Z","timestamp":1696224573000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002817","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}